Search Results | Newburgh Free Library

Catalog Search Results

Showing Results using Keyword index

Search instead using Subject index

Sort by

1) Deadly monopolies: the shocking corporate takeover of life itself, and the consequences for your health and our medical future

Author

Washington, Harriet A

Publisher

Doubleday

Pub. Date

c2011

Language

English

Description

Read Description

"An in-depth exploration of the way the pharmaceutical industry is manipulating us and our world"--Provided by publisher.

2) Sex, lies, + pharmaceuticals: how drug companies plan to profit from female sexual dysfunction

Author

Moynihan, Ray

Publisher

Greystone Books

Pub. Date

c2010

Language

English

Description

Read Description

Reveals how womens' sexual difficulties are being repackaged as symptoms of a new disorder and investigates the creation of female sexual dysfunction or FSD, and the marketing machine that promises to "cure" it.

3) Selling sickness: how the world's biggest pharmaceutical companies are turning us all into patients

Author

Moynihan, Ray

Publisher

Nation Books

Pub. Date

c2005

Language

English

4) Our daily meds: how the pharmaceutical companies transformed themselves into slick marketing machines and hooked the nation on prescription drugs

Author

Petersen, Melody

Publisher

Farrar, Straus and Giroux

Pub. Date

2008

Language

English

5) The proposed merger between Express Scripts and Medco: hearing before the Subcommittee on Intellectual Property, Competition, and the Internet of the Committee on the Judiciary, House of Representatives, One Hundred Twelfth...

Author

United States. Congress. House. Committee on the Judiciary. Subcommittee on Intellectual Property, Competition, and the Internet

Publisher

U.S. G.P.O

Pub. Date

2011

Language

English

6) Direct-to-consumer advertising of prescription drugs: what are the consequences? : hearing before the Special Committee on Aging, United States Senate, One Hundred Eighth Congress, first session, Washington, DC, July 22, 2003

Author

United States. Congress. Senate. Special Committee on Aging

Series

S. hrg volume 108-183

Publisher

U.S. G.P.O

Pub. Date

2003

Language

English

7) Safeguarding America's Pharmaceuticals Act of 2013: report together with dissenting views (to accompany H.R. 1919) (including cost estimate of the Congressional Budget Office)

Author

United States. Congress. House. Committee on Energy and Commerce

Series

Report / 113th Congress 1st session House of Representatives volume 113-93

Publisher

[U.S. Government Printing Office]

Pub. Date

[2013]

Language

English

Formats

Book, Web-Based Document

8) Pharmaceutical supply chain security: hearing before the Subcommittee on Criminal Justice, Drug Policy, and Human Resources of the Committee on Government Reform, House of Representatives, One Hundred Ninth...

Author

United States. Congress. House. Committee on Government Reform. Subcommittee on Criminal Justice, Drug Policy, and Human Resources

Publisher

U.S. G.P.O

Pub. Date

2007

Language

English

9) Evaluating the propriety and adequacy of the Oxycontin criminal settlement: hearing before the Committee on the Judiciary, United States Senate, One Hundred Tenth Congress, first session, July 31, 2007

Author

United States. Congress. Senate. Committee on the Judiciary

Series

S. hrg volume 110-479

Publisher

U.S. G.P.O

Pub. Date

2008

Language

English

10) Rogue online pharmacies: the growing problem of Internet drug trafficking : hearing before the Committee on the Judiciary, United States Senate, One Hundred Tenth Congress, first session, May 16, 2007

Author

United States. Congress. Senate. Committee on the Judiciary

Series

S. hrg volume 110-472

Publisher

U.S. G.P.O

Pub. Date

2008

Language

English

11) The role of Purdue Pharma and the Sackler family in the opioid epidemic: hearing before the Committee on Oversight and Reform, House of Representatives, One Hundred Sixteenth Congress, second session, December 17, 2020

Author

United States. Congress. House. Committee on Oversight and Reform

Publisher

U.S. Government Publishing Office

Pub. Date

2021.

Language

English

12) Examining advertising and marketing practices within the substance use treatment industry: hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Fifteenth Congress, second...

Author

United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations

Publisher

U.S. Government Publishing Office

Pub. Date

2019.

Language

English

13) The role of Purdue Pharma and the Sackler family in the opioid epidemic: hearing before the Committee on Oversight and Reform, House of Representatives, One Hundred Sixteenth Congress, second session, December 17, 2020

Author

United States. Congress. House. Committee on Oversight and Reform

Publisher

U.S. Government Publishing Office

Pub. Date

2021.

Language

English

Formats

Book, Web-Based Document

14) Direct to consumer advertising (DTC): hearing before the Subcommittee on Consumer Affairs, Foreign Commerce, and Tourism of the Committee on Commerce, Science, and Transportation, United States Senate, One Hundred...

Author

United States. Congress. Senate. Committee on Commerce, Science, and Transportation. Subcommittee on Consumer Affairs, Foreign Commerce, and Tourism

Series

S. hrg volume 107-986

Publisher

U.S. G.P.O

Pub. Date

2004

Language

English

15) Guidance for FDA staff and industry: marketed unapproved drugs, compliance policy guide

Publisher

U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research

Pub. Date

[2006]

Language

English

16) Guidance for industry: submitting marketing applications according to the ICH-CTD format, general considerations

Publisher

U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research

Pub. Date

[2001]

Language

English

17) An Act to Amend the Federal Food, Drug, and Cosmetic Act with Respect to Human Drug Compounding and Drug Supply Chain Security, and for Other Purposes

Author

United States

Publisher

[U.S. Government Printing Office]

Pub. Date

[2013]

Language

English

18) Pharmaceutical supply chain security

Author

Thaul, Susan

Series

CRS report volume R43106

Publisher

Congressional Research Service

Pub. Date

2019-

Language

English

19) The Orphan Drug Act: legal overview and policy considerations

Author

Rogers, Hannah-Alise

Series

In focus volume IF12605

Publisher

Congressional Research Service

Pub. Date

2024-

Language

English

20) Evaluating the propriety and adequacy of the Oxycontin criminal settlement: hearing before the Committee on the Judiciary, United States Senate, One Hundred Tenth Congress, first session, July 31, 2007

Author

United States. Congress. Senate. Committee on the Judiciary

Series

S. hrg volume 110-479

Publisher

U.S. G.P.O

Pub. Date

2008

Language

English

Navigation

Main Navigation

Filter Results

Narrow Your Results

Catalog Search Results

1) Deadly monopolies: the shocking corporate takeover of life itself, and the consequences for your health and our medical future

2) Sex, lies, + pharmaceuticals: how drug companies plan to profit from female sexual dysfunction

3) Selling sickness: how the world's biggest pharmaceutical companies are turning us all into patients

4) Our daily meds: how the pharmaceutical companies transformed themselves into slick marketing machines and hooked the nation on prescription drugs

5) The proposed merger between Express Scripts and Medco: hearing before the Subcommittee on Intellectual Property, Competition, and the Internet of the Committee on the Judiciary, House of Representatives, One Hundred Twelfth...

6) Direct-to-consumer advertising of prescription drugs: what are the consequences? : hearing before the Special Committee on Aging, United States Senate, One Hundred Eighth Congress, first session, Washington, DC, July 22, 2003

7) Safeguarding America's Pharmaceuticals Act of 2013: report together with dissenting views (to accompany H.R. 1919) (including cost estimate of the Congressional Budget Office)

8) Pharmaceutical supply chain security: hearing before the Subcommittee on Criminal Justice, Drug Policy, and Human Resources of the Committee on Government Reform, House of Representatives, One Hundred Ninth...

9) Evaluating the propriety and adequacy of the Oxycontin criminal settlement: hearing before the Committee on the Judiciary, United States Senate, One Hundred Tenth Congress, first session, July 31, 2007

10) Rogue online pharmacies: the growing problem of Internet drug trafficking : hearing before the Committee on the Judiciary, United States Senate, One Hundred Tenth Congress, first session, May 16, 2007

11) The role of Purdue Pharma and the Sackler family in the opioid epidemic: hearing before the Committee on Oversight and Reform, House of Representatives, One Hundred Sixteenth Congress, second session, December 17, 2020

12) Examining advertising and marketing practices within the substance use treatment industry: hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Fifteenth Congress, second...

13) The role of Purdue Pharma and the Sackler family in the opioid epidemic: hearing before the Committee on Oversight and Reform, House of Representatives, One Hundred Sixteenth Congress, second session, December 17, 2020

14) Direct to consumer advertising (DTC): hearing before the Subcommittee on Consumer Affairs, Foreign Commerce, and Tourism of the Committee on Commerce, Science, and Transportation, United States Senate, One Hundred...

15) Guidance for FDA staff and industry: marketed unapproved drugs, compliance policy guide

16) Guidance for industry: submitting marketing applications according to the ICH-CTD format, general considerations

17) An Act to Amend the Federal Food, Drug, and Cosmetic Act with Respect to Human Drug Compounding and Drug Supply Chain Security, and for Other Purposes

18) Pharmaceutical supply chain security

19) The Orphan Drug Act: legal overview and policy considerations

20) Evaluating the propriety and adequacy of the Oxycontin criminal settlement: hearing before the Committee on the Judiciary, United States Senate, One Hundred Tenth Congress, first session, July 31, 2007